Vault-13

XERIS BIOPHARMA HOLDINGS INC XERS 8 07.15.28

NOTE 8.000% 7/1 · US DOMESTIC · CUSIP 98422EAB9

3 institutional holders -1 vs Q1 2025
$33.6mprincipal reported held*
$56.9mreported value*
0 new 1 added 0 reduced 1 sold out net bought ≈ $0

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q2 2025

Institutional holders

Managers reporting a position, each quarter

024Q1 25: 4Q2 25: 33Q1 25Q2 25
Numbers
QuarterHolders
Q1 20254
Q2 20253

Biggest buyers

CAPSTONE INVESTMENT ADVISORS, LLC Added +2,174,000+2.2m

Biggest sellers

Sessa Capital IM, L.P. Sold out -2,174,000-2.2m

Holders, Q2 2025

#ManagerLocationShares Value% of their portfolioChangeShares change
1 CAPSTONE INVESTMENT ADVISORS, LLC 0.33% of their portfolio NEW YORK, NY 23,074,00023.1m $39.2m $39.2m 0.33% Added +2.2m +2,174,000
2 DEERFIELD MANAGEMENT COMPANY, L.P. 0.32% of their portfolio New York, NY 10,500,00010.5m $17.7m $17.7m 0.32% Unchanged
3 CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio BIRMINGHAM, AL 00 $0 $0 — Unchanged